Teva Enters Agreement With Kentucky To Settle The State's Price Fixing Claims; Agrees To Pay $1.407M
Portfolio Pulse from Benzinga Newsdesk
Teva Pharmaceuticals has reached an agreement with the Attorney General of Kentucky to settle the state's price-fixing claims against the company. Teva will pay $1.407 million, and the state will dismiss all claims against Teva and its affiliates.

June 12, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Teva Pharmaceuticals settles price-fixing claims with Kentucky for $1.407 million, leading to the dismissal of all claims against the company and its affiliates.
Teva has reached a settlement with Kentucky, which will result in the dismissal of all claims against the company and its affiliates. This settlement may have a neutral short-term impact on Teva's stock price, as the payment of $1.407 million is relatively small compared to the company's overall financials. However, the resolution of legal issues can be seen as a positive development for the company.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100